EGFR and cancer: Their crosstalk with cancer cells is mediated through a complex signal network that includes TGF-β, mitogen-activated protein kinase (MAPK), Wnt/β-signal pathways such as catenin, Janus kinase/signal transduction, and transcription activating factors (JAK/STATs), and epidermal growth factor receptors (EGFR) [66].